RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma. - Hazar-Rethinam M; de Long LM; Gannon OM; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Saenz-Ponce N; Dantzic DD; Simpson F; Saunders NA (Molecular cancer therapeutics, 2015)